Benefit of Dapagliflozin When Used With Cardiovascular Medications in Patients With Type 2 Diabetes

被引：0
|
作者：
Slomski, Anita
机构：
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2022年 / 328卷 / 09期
关键词：
D O I：
10.1001/jama.2022.14696
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：817 / 817
页数：1
相关论文
共 50 条
  • [1] Dapagliflozin and cardiovascular outcomes in patients with Type 2 diabetes
    Al-Bazz, Dalai Y.
    Wilding, John P. H.
    [J]. FUTURE CARDIOLOGY, 2020, 16 (02) : 77 - 88
  • [2] Cardiovascular Outcomes with Dapagliflozin for Patients with Type 2 Diabetes
    Pavlicek, Vojtech
    [J]. DIABETOLOGE, 2019, 15 (03): : 262 - 264
  • [3] Renal Benefit of Dapagliflozin Therapy in Hyperfiltering Type 2 Diabetes Patients
    Baskoy, Gozde
    Qin, Yuejuan
    Cersosimo, Eugenio
    Solis-Herrera, Carolina
    Adams, John M., III
    Defronzo, Ralph A.
    Triplitt, Curtis L.
    [J]. DIABETES, 2023, 72
  • [4] Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
    Wiviott, S. D.
    Raz, I.
    Bonaca, M. P.
    Mosenzon, O.
    Kato, E. T.
    Cahn, A.
    Silverman, M. G.
    Zelniker, T. A.
    Kuder, J. F.
    Murphy, S. A.
    Bhatt, D. L.
    Leiter, L. A.
    McGuire, D. K.
    Wilding, J. P. H.
    Ruff, C. T.
    Gause-Nilsson, I. A. M.
    Fredriksson, M.
    Johansson, P. A.
    Langkilde, A-M.
    Sabatine, M. S.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (04): : 347 - 357
  • [5] Dapagliflozin and measures of cardiovascular autonomic function in patients with type 2 diabetes
    Ang, L.
    Kidwell, K.
    Dillon, B.
    Reiss, J.
    Leone, V.
    Mizokami-Stout, K.
    Busui, R.
    [J]. DIABETOLOGIA, 2020, 63 (SUPPL 1) : S406 - S406
  • [6] Dapagliflozin and Measures of Cardiovascular Autonomic Function in Patients with Type 2 Diabetes
    Ang, Lynn
    Kidwell, Kelley M.
    Reiss, Jacob
    Dillon, Brendan R.
    Mizokami-Stout, Kara R.
    Leone, Virginia A.
    Pop-Busui, Rodica
    [J]. DIABETES, 2020, 69
  • [7] Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes Reply
    Wiviott, Stephen D.
    Raz, Itamar
    Sabatine, Marc S.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (19): : 1881 - 1882
  • [8] Blood Pressure Reduction With Dapagliflozin in Patients With Type 2 Diabetes and Cardiovascular Disease
    Woo, Vincent
    Leiter, Lawrence A.
    Cefalu, William T.
    de Bruin, Tjerk W.
    Gause-Nilsson, Ingrid
    Parikh, Shamik J.
    Johnsson, Eva
    [J]. CIRCULATION, 2013, 128 (22)
  • [9] Influence of dapagliflozin on cardiovascular remodeling in hypertensive patients with accompanying type 2 diabetes
    Bohun, A. O.
    [J]. PATHOLOGIA, 2024, 21 (01): : 41 - 50
  • [10] Dapagliflozin treatment for type 2 diabetes mellitus patients with a history of cardiovascular disease
    Leiter, L.
    Cefalu, W.
    DeBruin, T.
    Gause-Nilsson, I.
    Sugg, J.
    Parikh, S.
    [J]. DIABETOLOGIA, 2012, 55 : S310 - S311
12345